Foam carrier for bone grafting
AssigneeWarsaw Orthopedic, Inc.
InventorJeffrey L. Scifert
Life of this patent
Estimating the term…
Abstract
An improved osteogenic composition is provided. The composition comprises a foam that contains polymer beads having one or more growth factors such as bone morphogenic protein. Through use of this composition, bone, collagen and/or other tissue growth may be facilitated.
Claims10
A method for accelerating bone repair in a patient in need of such treatment, the method comprising implanting at a target tissue site in need of replacement bone, an osteogenic composition comprising:
- a porous foam, wherein said porous foam contains a plurality of pores between about 100 micrometers and about 350 micrometers at their widest points;
- polymeric beads, wherein said polymeric beads comprise immediate release beads and sustained release beads for delivering an isolated osteoinductive agent, the isolated osteoinductive agent comprising a sterile growth factor, said polymeric beads comprising the sterile growth factor, an excipient in an amount of from about 0.05 wt. % to about 85 wt. %, and sterile preservative free material;
- and
- a polymer, wherein the excipient is mPEG.
A method for accelerating bone repair in a patient in need of such treatment, the method comprising implanting at a target tissue site in need of replacement bone, an osteogenic composition comprising:
- polymeric beads comprising immediate release beads and sustained release beads for delivering an isolated osteoinductive agent, the isolated osteoinductive agent comprising a sterile growth factor at or near the target tissue site;
- the polymeric beads comprising the sterile growth factor, an excipient in an amount of from about 0.05 wt. % to about 85 wt. %, a viscosity enhancing agent, degradation/release modifiers and sterile preservative free material;
- and
- a porous foam comprising layers such that the immediate release beads and sustained release beads are disposed throughout the layers of the foam, the porous foam being biodegradable and containing a plurality of pores having a size between about 100 micrometers and about 350 micrometers at their widest points,
- wherein the growth factor comprises bone morphogenic protein in an amount from 1 to 2 mg per cubic centimeter of said osteogenic composition, and the foam has a density of between about 0.2 g/cm3 to about 1.1 g/cm3, and the porous foam comprises seeded bone cells or tissue, wherein the excipient is mPEG.
Dependencies are inferred from the claim text.